Molecular Imaging 2017
Clinical Trials:
Safety/Toxicity/Dosage Phase I
Phase II
Phase III
Randomisation Tested vs standard treatment
Therapy effectiveness Safety
Question: Is the therapy safe & is there biological activity?
Question: Does the therapy work sufficiently well?
Question: How well does the therapy compare to what we have?
Go/No go
Go/No go
Response criteria
Made with FlippingBook - Online magazine maker